Sessions Were Renumbered as of May 19.
		
		Legend: 
    CC-W  = McCormick Place Convention Center, West Building,   
CC-N  = McCormick Place Convention Center, North Building
    
H  = Hilton Chicago,   
UC = Conference Chicago at University Center
		
		* = applied session       ! = JSM meeting theme
	
 
	
		
				
						 
		
			
	
		 
		
	 
	
		
			 397 *   
		 
		
			 Tue, 8/2/2016, 
				2:00 PM -
				3:50 PM  
		 
		
			
			CC-W196b  
	 
	
		
			Innovative Trial Designs and Data Analysis Models in Rare Diseases — Invited Papers 
		 
	 
	
		
			 Biopharmaceutical Section   , International Chinese Statistical Association 
		 
	 
	
	
		
			Organizer(s): Freda  Cooner, FDA/CDER/OTS/OB/DB2 
		 
	 
	
	
		
			Chair(s): Freda  Cooner, FDA/CDER/OTS/OB/DB2 
		 
	 
	
					
						
							2:05 PM 
						 
						
							Efficient Use of Deficient (Limited) Information: A Rare Disease Perspective  
							— 
							 Sandeep M. Menon, Pfizer   
						 
					 				
				
					
						
							2:20 PM 
						 
						
							The Statisticians Role as a Strategic Drug Developer in Rare Disease Indications  
							— 
							 Jeff  Palmer, Pfizer   
						 
					 				
				
					
						
							2:35 PM 
						 
						
							Case Studies for Biologics Trials in Very Rare Diseases  
							— 
							 John  Scott, FDA   
						 
					 				
				
					
						
							2:50 PM 
						 
						
							Issues and Solutions Encountered in the Design of Trials for Rare Diseases  
							— 
							 Brenda  Gaydos, Eli Lilly and Company   ; Karen  Price, Eli Lilly and Company ; Bill  Prucka, Eli Lilly and Company 
						 
					 				
				
					
						
							3:05 PM 
						 
						
							Hierarchical Bayesian Approaches for Clinical Trials in Orphan and Pediatric Diseases  
							— 
							 Cynthia  Basu, University of Minnesota   ; Freda  Cooner, FDA/CDER/OTS/OB/DB2 ; Ram  Tiwari, FDA/CDER/OT/OB ; Bradley  Carlin, University of Minnesota 
						 
					 				
				
	
		
			3:20 PM
		 
		
			Discussant:  Amy  Xia, Amgen
		 
	 	
	
		3:35 PM
	 
	
		Floor Discussion